Short Interest in CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Declines By 98.0%

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the recipient of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 100 shares, a decline of 98.0% from the November 15th total of 4,900 shares. Based on an average trading volume of 34,700 shares, the days-to-cover ratio is currently 0.0 days.

CSPC Pharmaceutical Group Stock Performance

CSPCY traded down C$0.11 on Wednesday, reaching C$2.57. 13,288 shares of the company’s stock were exchanged, compared to its average volume of 40,351. CSPC Pharmaceutical Group has a twelve month low of C$2.25 and a twelve month high of C$3.82. The stock’s fifty day moving average price is C$2.90 and its 200-day moving average price is C$2.92.

CSPC Pharmaceutical Group Increases Dividend

The firm also recently declared a dividend, which was paid on Thursday, December 5th. Investors of record on Friday, November 1st were given a dividend of $0.0575 per share. The ex-dividend date of this dividend was Friday, November 1st. This is a positive change from CSPC Pharmaceutical Group’s previous dividend of $0.06.

CSPC Pharmaceutical Group Company Profile

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.